Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-23 4:06 pm Purchase |
2024-05-14 | 13G | Virpax Pharmaceuticals, Inc. VRPX |
Mitchell P. Kopin | 4,429 4.990% |
4,429 (New Position) |
Filing History |
| 2024-01-02 10:11 am Sale |
2023-12-31 | 13G | Virpax Pharmaceuticals, Inc. VRPX |
SABBY MANAGEMENT LLC | 0 0.000% |
-3,953 (Position Closed) |
Filing History |
| 2023-02-14 4:05 pm Purchase |
2022-12-31 | 13G | Virpax Pharmaceuticals, Inc. VRPX |
Mack Anthony P. | 12,322 26.100% |
451 (+3.80%) |
Filing History |
| 2023-01-26 4:05 pm Sale |
2022-12-31 | 13G | Virpax Pharmaceuticals, Inc. VRPX |
Kepos Capital LP | 0 0.000% |
-3,000 (Position Closed) |
Filing History |
| 2023-01-10 1:36 pm Purchase |
2022-12-31 | 13G | Virpax Pharmaceuticals, Inc. VRPX |
SABBY MANAGEMENT LLC | 3,953 11.000% |
445 (+12.70%) |
Filing History |
| 2022-02-14 4:34 pm Purchase |
2021-12-31 | 13G | Virpax Pharmaceuticals, Inc. VRPX |
Mack Anthony P. | 11,872 25.200% |
11,872 (New Position) |
Filing History |
| 2022-02-14 3:23 pm Sale |
2021-12-31 | 13G | Virpax Pharmaceuticals, Inc. VRPX |
CVI Investments, Inc. | 0 0.000% |
-4,000 (Position Closed) |
Filing History |
| 2022-02-04 08:18 am Purchase |
2021-12-31 | 13G | Virpax Pharmaceuticals, Inc. VRPX |
Kepos Capital LP | 3,000 6.400% |
3,000 (New Position) |
Filing History |
| 2022-01-04 11:31 am Sale |
2021-12-31 | 13G | Virpax Pharmaceuticals, Inc. VRPX |
SABBY MANAGEMENT LLC | 3,507 11.000% |
-493 (-12.32%) |
Filing History |
| 2021-09-23 07:29 am Purchase |
2021-09-14 | 13G | Virpax Pharmaceuticals, Inc. VRPX |
SABBY MANAGEMENT LLC | 4,000 11.000% |
4,000 (New Position) |
Filing History |
| 2021-09-21 4:33 pm Purchase |
2021-09-14 | 13G | Virpax Pharmaceuticals, Inc. VRPX |
Altium Capital Management LLC | 4,000 8.500% |
4,000 (New Position) |
Filing History |
| 2021-09-20 10:32 am Purchase |
2021-09-14 | 13G | Virpax Pharmaceuticals, Inc. VRPX |
CVI Investments, Inc. | 4,000 8.500% |
4,000 (New Position) |
Filing History |